Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
United Natural Foods, Inc. Reports Fourth Quarter and Full Year Fiscal 2026 Results
-
Thick, High-Grade, Surface Enrichment Zone Extends at La Verde
-
BrainChild Bio Closes $116 Million Series A Financing
-
Hirain and Arbe Selected by One of the World's Largest Automotive Groups for Level 3 Program Across Multiple Brands
-
CI Global Asset Management Announces Risk Rating Change for CI Floating Rate Income Fund
-
Limitless MFG Ranks No. 1 in Apparel Manufacturing on the 2026 Inc. 5000 List of America’s Fastest-Growing Private Companies
-
U.S. Bank Introduces Private Waterfall Engine to Automate Alternative Fund Calculations
-
Pulsenmore Expands into Fertility Care: Completes CE European Registration of Home Ultrasound System for Follicular Monitoring
-
Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer
-
Genesys Featured on Fast Company’s Eighth Annual List of the 100 Best Workplaces for Innovators
-
Solstice Gold Announces Closing of Fully Subscribed Private Placement
-
D-Wave Quantum Finalizes Definitive Agreement with U.S. Department of Commerce for up to $100 Million to Accelerate U.S. Leadership in Quantum Computing
-
Alterome Therapeutics Appoints Johanna Mylet as Chief Financial Officer
-
United Therapeutics Corporation Announces Accelerated Share Repurchase Agreement for Remainder of $2.0 Billion Authorization
-
Durable Surfaces Names Matt Joyner Chief Executive Officer
-
Rohati Capital Closes Oversubscribed $50 Million Inaugural Fund
-
OneWater Marine Inc. Announces Change to Board of Directors
-
Canada Goose Announces Participation in Goldman Sachs 33rd Annual Global Consumer & Retail Conference
-
Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
-
Compugen to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference
-
Palladyne AI and FANUC America Announce Strategic Collaboration to Advance Intelligent Robotic Automation
-
VION Biosciences Expands Integrated Platform Across Biopharma Services and Diagnostic Workflow Capabilities
-
Definium Therapeutics Receives Breakthrough Therapy Designation for DT120 (lysergide) Orally Disintegrating Tablet (ODT) in Major Depressive Disorder (MDD) Following Positive Phase 3 Results
-
NetraMark Appoints Former Global Atlantic Investment Office President and Scotiabank U.S. CEO Kevin Felix as Strategic Advisor
-
LX Pantos Successfully Completes Complex Defense Logistics Project for Advanced Weapons
-
BETA Technologies to Participate in Upcoming Investor Conferences
-
CDAO Awards Red Cell Partners $100M Agreement to Pilot Shared Savings
-
BrewDog Roars into Rugby with Five-Year Leicester Tigers Partnership, Bringing Punk Energy to Welford Road
-
Erasca to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
-
OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference
-
Beamr and VAST Data Partner to AI-enhance and Monetize Video Archives with NVIDIA
-
Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
-
NRx Pharmaceuticals to Participate in Upcoming Investor Conferences
-
DraftKings Extends Agreement with IC360 to Enhance Integrity Monitoring and Combat Athlete Harassment Across Sportsbook and Prediction Market Platforms
-
Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer
-
Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC
-
Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
-
LiveU, AP bring new connectivity, workflow tech to global newsgathering, deploying largest LU900Q fleet worldwide
-
Cloverleaf Bio Raises $33 Million Seed Financing to Advance Novel RNA-Based Cancer Therapeutics
-
Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development
-
CoinShares Co-Founder and Non-Executive Director Daniel Masters Adopts Pre-Scheduled Trading Plan
-
A New Force in the Surf Park Economy
-
Palantir and Nebius Partner to Deliver a Complete Sovereign AI Stack to Palantir Customers
-
Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 QUINTESSENTIAL Trial of the Potential First-in-Class GPRC5D-Directed CAR T Cell Therapy, Arlocabtagene Autoleucel ..
-
ABM Reports Fiscal Third Quarter 2026 Results
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
-
YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
-
A Winning Partnership for Veterans: Glocoms Inc. and Dr. Maurence Anguh Selected for VA Driver Rehabilitation Services
-
Treno Scope Launches Liquidity Analysis Module, with Initial Focus on the Indonesian Market
-
Pharvaris Announces Positive Topline Data from CHAPTER-3 Pivotal Study of Deucrictibant XR for Prophylaxis of HAE Attacks
